The activation of the PDGFR and ABL1 pathways is associated with long-term estrogen deprivation in MCF7 breast cancer cells and decreased anti-proliferative response to AI treatment in primary ER-positive breast carcinomas. This evidence concerns the gene ABL1 and breast cancer.